Patents Assigned to Pfizer Vaccines, LLC
  • PCSK9 vaccine
    Patent number: 9987341
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: June 5, 2018
    Assignee: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, Jr., Leonard Gabriel Contillo, Jr., Michael Dale Eisenbraun, James Downey Fraser, Julie Jia Li Hawkins, James Richard Merson, Brian Gregory Pierce, Xiayang Qiu, Jakir Hussain Ullah, David Michael Wyatt
  • PCSK9 vaccine
    Patent number: 9481875
    Abstract: The present invention relates to the provision of immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: November 1, 2016
    Assignee: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, Leonard Gabriel Contillo, Jr., Michael Dale Eisenbraun, James Downey Fraser, Julie Jia Li Hawkins, James Richard Merson, Brian Gregory Pierce, Xiayang Qiu, Jakir Hussain Ullah, David Michael Wyatt
  • IgE CH3 peptide vaccine
    Patent number: 9249233
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: February 2, 2016
    Assignee: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, David Robert Stead, Paul Andrew Wright
  • IgE CH3 peptide vaccine
    Patent number: 9216229
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: May 29, 2013
    Date of Patent: December 22, 2015
    Assignee: Pfizer Vaccines LLC
    Inventors: Alan Daniel Brown, Brian Robert Champion, Clare Lees, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
  • IGE CH3 Peptide Vaccine
    Publication number: 20150118256
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: March 25, 2014
    Publication date: April 30, 2015
    Applicant: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, David Robert Stead, Paul Andrew Wright
  • PCSK9 VACCINE
    Publication number: 20150098957
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: October 7, 2014
    Publication date: April 9, 2015
    Applicant: PFIZER VACCINES LLC
    Inventors: Brian Robert Champion, Leonard Gabriel Contillo, JR., Michael Dale Eisenbraun, James Downey Fraser, Julie Jia Li Hawkins, James Richard Merson, Brian Gregory Pierce, Xiayang Qiu, Jakir Hussain Ullah, David Michael Wyatt
  • PCSK9 vaccine
    Patent number: 8889144
    Abstract: The present invention relates to the provision of immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: August 31, 2010
    Date of Patent: November 18, 2014
    Assignee: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, Leonard Gabriel Contillo, Jr., Michael Dale Eisenbraun, James Downey Fraser, Julie Jia Li Hawkins, James Richard Merson, Brian Gregory Pierce, Xiayang Qiu, Jakir Hussain Ullah, David Michael Wyatt
  • IgE CH3 peptide vaccine
    Patent number: 8722053
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: May 13, 2014
    Assignee: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, David Robert Stead, Paul Andrew Wright
  • IGE CH3 Peptide Vaccine
    Publication number: 20140017239
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: May 29, 2013
    Publication date: January 16, 2014
    Applicant: PFIZER VACCINES LLC
    Inventors: Alan Daniel Brown, Brian Robert Champion, Clare Christy, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
  • IGE CH3 Peptide Vaccine
    Publication number: 20120294848
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: August 1, 2012
    Publication date: November 22, 2012
    Applicant: PFIZER VACCINES LLC
    Inventors: Alan Daniel Brown, Brian Robert Champion, Clare Christy, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
  • IgE CH3 peptide vaccine
    Patent number: 8298547
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Grant
    Filed: December 9, 2009
    Date of Patent: October 30, 2012
    Assignee: Pfizer Vaccines, LLC
    Inventors: Alan Daniel Brown, Brian Robert Champion, Clare Christy, David Paul Gervais, Lyn Howard Jones, Anne Maria Kristina Kjerrstrom, David Cameron Pryde, Lee Richard Roberts, David Michael Wyatt
  • CONJUGATES FOR THE PREVENTION OR TREATMENT OF NICOTINE ADDICTION
    Publication number: 20110300174
    Abstract: The present invention relates in part to nicotine-derived hapten-carrier conjugates of the formula (III): wherein m, n, W, -(spacer)-, X* and Y are as defined in the description. In certain embodiments, said nicotine-derived hapten-carrier conjugates can be used to prepare vaccines for the treatment and/or prevention of nicotine addiction.
    Type: Application
    Filed: June 2, 2011
    Publication date: December 8, 2011
    Applicant: Pfizer Vaccines LLC
    Inventors: Alan Daniel BROWN, Heather Lynn DAVIS, David P. GERVAIS, Lyn Howard JONES, James R. MERSON, David Cameron PRYDE, David R. STEAD, Michael J. MCCLUSKIE, Jennifer Marie THORN, Paul Robert MEHELIC, Parag Ashok KOLHE, Keshab BHATTACHARYA, Jari Ilmari FINNEMAN, Erin Kristen PARSONS, Nickolas ANASTASIOU
  • ANTIGENIC TAU PEPTIDES AND USES THEREOF
    Publication number: 20110177109
    Abstract: The present disclosure relates to novel immunogens and compositions comprising an antigenic tau peptide, preferably linked to an immunogenic carrier for use in the treatment of tau-related neurological disorders. The disclosure further relates to methods for production of these immunogens and compositions and their use in medicine.
    Type: Application
    Filed: July 29, 2010
    Publication date: July 21, 2011
    Applicant: PFIZER VACCINES LLC
    Inventors: George Joseph Smith, III, Kenneth Nelson Wills, Jeff Xianchao Zhu
  • PCSK9 VACCINE
    Publication number: 20110052621
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic PCSK9 peptide linked to an immunogenic carrier for the prevention, treatment or alleviation of PCSK9-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: August 31, 2010
    Publication date: March 3, 2011
    Applicant: Pfizer Vaccines LLC
    Inventors: Brian Robert Champion, Leonard Gabriel Contillo, JR., Michael Dale Eisenbraun, James Downey Fraser, Julie Jia Li Hawkins, James Richard Merson, Brian Gregory Pierce, Xiayang Qiu, Jakir Hussain Ullah, David Michael Wyatt
  • IGE CH3 PEPTIDE VACCINE
    Publication number: 20100158933
    Abstract: The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
    Type: Application
    Filed: December 9, 2009
    Publication date: June 24, 2010
    Applicant: PFIZER VACCINES LLC
    Inventors: ALAN DANIEL BROWN, BRIAN ROBERT CHAMPION, CLARE CHRISTY, DAVID PAUL GERVAIS, LYN HOWARD JONES, ANNE MARIA KRISTINA KJERRSTROM, DAVID CAMERON PRYDE, LEE RICHARD ROBERTS, DAVID MICHAEL WYATT